A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

NCT00942175 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Clopidogrel
DRUG: Clopidogrel and Lansoprazole
DRUG: Clopidogrel and Dexlansoprazole
DRUG: Clopidogrel and Omeprazole
DRUG: Clopidogrel and Esomeprazole

Sponsor

Takeda